Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 6 (June)

1. The impact of detecting bipolar disorder in previously diagnosed unipolar patients at a specialist depression clinic.
   J Nerv Ment Dis, 199(6): 419-22. [Abstract] [Full-text]
2. Cognitive functioning in recent onset psychosis.
   J Nerv Ment Dis, 199(6): 367-71. [Abstract] [Full-text]
3. Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations.
   J Clin Pharmacol. [Abstract] [Full-text]
4. Synaptic Wnt signaling-a contributor to major psychiatric disorders?
   J Neurodev Disord, 3(2): 162-74. [Abstract] [Full-text]
5. Lithium in drinking water and thyroid function.
   Environ Health Perspect, 119(6): 827-30. [Abstract] [Full-text]
6. An online recovery plan program: can peer coaching increase participation?
   Psychiatr Serv, 62(6): 666-9. [Abstract] [Full-text]
7. Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study.
   Psychiatr Serv, 62(6): 650-8. [Abstract] [Full-text]
8. Affective lability in bipolar disorder and borderline personality disorder.
   Compr Psychiatry. [Abstract] [Full-text]
9. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study.
   Psychiatry Res. [Abstract] [Full-text]
10. Exonic DNA sequencing of ERBB4 in bipolar disorder.
    PLoS One, 6(5): e20242. [Abstract] [Full-text]
11. Antidepressant-like responses to lithium in genetically diverse mouse strains.
    Genes Brain Behav, 10(4): 434-43. [Abstract] [Full-text]
12. Bipolar disorder risk alleles in adult ADHD patients.
    Genes Brain Behav, 10(4): 418-23. [Abstract] [Full-text]
13. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
    Neuromolecular Med, 13(2): 93-116. [Abstract] [Full-text]
14. Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders.
    Compr Psychiatry. [Abstract] [Full-text]
15. Childhood trauma, impulsivity, and executive functioning in crack cocaine users.
    Compr Psychiatry. [Abstract] [Full-text]
16. Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(5): 1349-54. [Abstract] [Full-text]
17. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(5): 1303-8. [Abstract] [Full-text]
18. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.
    Behav Neurosci, 125(3): 282-96. [Abstract] [Full-text]
19. Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.
    J Affect Disord, 132(1): 209-15. [Abstract] [Full-text]
20. Seasonal symptoms in bipolar and primary care patients.
    J Affect Disord, 132(1): 200-8. [Abstract] [Full-text]
21. Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression.
    J Affect Disord, 132(1): 297-300. [Abstract] [Full-text]
22. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    J Affect Disord, 132(1): 293-6. [Abstract] [Full-text]
23. Examining the validity of cyclothymic disorder in a youth sample.
    J Affect Disord, 132(1): 55-63. [Abstract] [Full-text]
24. The seasonality of bipolar affective disorder: comparison with a primary care sample using the Seasonal Pattern Assessment Questionnaire.
    J Affect Disord, 132(1): 289-92. [Abstract] [Full-text]
25. From items to syndromes in the Hypomania Checklist (HCL-32): psychometric validation and clinical validity analysis.
    J Affect Disord, 132(1): 48-54. [Abstract] [Full-text]
26. Pediatric bipolar disorder in a Spanish sample: results after 2.6years of follow-up.
    J Affect Disord, 132(1): 270-4. [Abstract] [Full-text]
27. Elevated daytime cortisol levels: a biomarker of subsequent major affective disorder?
    J Affect Disord, 132(1): 265-9. [Abstract] [Full-text]
28. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques.
    J Affect Disord, 132(1): 1-13. [Abstract] [Full-text]
29. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
30. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.
    Schizophr Res, 129(2): 183-90. [Abstract] [Full-text]
31. Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia.
    Schizophr Res, 129(2): 191-5. [Abstract] [Full-text]
32. Paternal age and psychiatric disorders: findings from a Dutch population registry.
    Schizophr Res, 129(2): 128-32. [Abstract] [Full-text]
33. Role of sublingual asenapine in treatment of schizophrenia.
    Neuropsychiatr Dis Treat, 7: 325-39. [Abstract] [Full-text]
34. Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence.
    Neuropsychiatr Dis Treat, 7: 319-23. [Abstract] [Full-text]
35. Scaling behavior of human locomotor activity amplitude: association with bipolar disorder.
    PLoS One, 6(5): e20650. [Abstract] [Full-text]
36. The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder.
    Neuropsychiatr Dis Treat, 7: 259-65. [Abstract] [Full-text]
37. Creativity and mental disorder: family study of 300 000 people with severe mental disorder.
    Br J Psychiatry. [Abstract] [Full-text]
38. Toward Caring for Oneself in a Life of Intense Ups and Downs: A Reflexive-Collaborative Exploration of Recovery in Bipolar Disorder.
    Qual Health Res. [Abstract] [Full-text]
39. Brain functional domains inform therapeutic interventions in attention-deficit/hyperactivity disorder and pediatric bipolar disorder.
    Expert Rev Neurother, 11(6): 897-914. [Abstract] [Full-text]
40. Quetiapine monotherapy for bipolar depression.
    Expert Opin Pharmacother, 12(10): 1643-51. [Abstract] [Full-text]
41. Modeling mania: Further validation for Black Swiss mice as model animals.
    Behav Brain Res, 223(1): 222-6. [Abstract] [Full-text]
42. Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes.
    Genet Epidemiol, 35(5): 318-32. [Abstract] [Full-text]
43. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases.
    Genet Epidemiol, 35(5): 310-7. [Abstract] [Full-text]
44. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
    Int Clin Psychopharmacol, 26(4): 183-92. [Abstract] [Full-text]
45. Modeling mania: Further validation for Black Swiss mice as model animals.
    Behav Brain Res, 223(1): 222-6. [Abstract] [Full-text]
46. Quetiapine dependence and withdrawal: a case report.
    Subst Abus, 32(3): 168-9. [Abstract] [Full-text]
47. Predictors of good outcome in patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment.
    Compr Psychiatry. [Abstract] [Full-text]
48. The pharmacologic treatment of bipolar disorder.
    J Clin Psychiatry, 72(5): 704-15. [Abstract] [Full-text]
49. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
    J Clin Psychiatry, 72(5): 655-70. [Abstract] [Full-text]
50. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study.
    J Clin Psychiatry, 72(5): 580-6. [Abstract] [Full-text]
51. Bipolar disorder self-assessment.
    J Clin Psychiatry, 72(5): e16. [Abstract] [Full-text]
52. Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies.
    J Abnorm Child Psychol, 39(6): 773-82. [Abstract] [Full-text]
53. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(5): 536-45. [Abstract] [Full-text]
54. Ethnic disparities in the perception of ethical risks from psychiatric genetic studies.
    Am J Med Genet B Neuropsychiatr Genet, 156(5): 569-80. [Abstract] [Full-text]
55. Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain.
    J Clin Psychiatry, 72(5): 671-6. [Abstract] [Full-text]
56. Subsyndromal depressive symptoms after symptomatic recovery from mania are associated with delayed functional recovery.
    J Clin Psychiatry, 72(5): 692-7. [Abstract] [Full-text]
57. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients.
    Compr Psychiatry. [Abstract] [Full-text]
58. A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report.
    J Child Adolesc Psychopharmacol, 21(3): 275-80. [Abstract] [Full-text]
59. An open-label trial of risperidone in children and adolescents with severe mood dysregulation.
    J Child Adolesc Psychopharmacol, 21(3): 237-43. [Abstract] [Full-text]
60. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.
    J Child Adolesc Psychopharmacol, 21(3): 195-205. [Abstract] [Full-text]
61. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
62. Dissociable functional connectivity changes during the Stroop task relating to risk, resilience and disease expression in bipolar disorder.
    Neuroimage, 57(2): 576-82. [Abstract] [Full-text]
63. γ-Hydroxybutyric acid-induced psychosis and seizures.
    Epilepsy Behav, 21(2): 203-5. [Abstract] [Full-text]
64. Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity.
    Neurobiol Dis, 43(2): 372-8. [Abstract] [Full-text]
65. Structural and functional impairments of polysialic acid by a mutated polysialyltransferase found in schizophrenia.
    J Biol Chem, 286(24): 21535-45. [Abstract] [Full-text]
66. Psychiatric illness in a cohort of adults with Prader-Willi syndrome.
    Res Dev Disabil, 32(5): 1729-35. [Abstract] [Full-text]
67. Body awareness in preschool children with psychiatric disorder.
    Res Dev Disabil, 32(5): 1623-30. [Abstract] [Full-text]
68. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
    Expert Opin Drug Saf, 10(4): 575-602. [Abstract] [Full-text]
69. The relationship between psychopathology symptom clusters and the presence of comorbid psychopathology in individuals with severe to profound intellectual disability.
    Res Dev Disabil, 32(5): 1610-4. [Abstract] [Full-text]
70. Benzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in Taiwan.
    Hum Psychopharmacol. [Abstract] [Full-text]
71. Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire.
    Value Health, 14(4): 564-70. [Abstract] [Full-text]
72. Progression along the bipolar spectrum: A longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders.
    J Abnorm Psychol. [Abstract] [Full-text]
73. Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium.
    J Cell Sci, 124: 2267-76. [Abstract] [Full-text]
74. Association of aggressive behaviours with psychiatric disorders, age, sex and degree of intellectual disability: a large-scale survey.
    J Intellect Disabil Res, 55(7): 636-49. [Abstract] [Full-text]
75. Anesthesia for Electroconvulsive Therapy in Early Pregnancy.
    J ECT. [Abstract] [Full-text]
76. Catatonia Among Adolescents With Down Syndrome: A Review and 2 Case Reports.
    J ECT. [Abstract] [Full-text]
77. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. [Abstract] [Full-text]
78. Event-related potential correlates of inhibition in bipolar disorder.
    Neuroreport, 22(10): 484-8. [Abstract] [Full-text]
79. Competition between Li+ and Mg2+ in metalloproteins. Implications for lithium therapy.
    J Am Chem Soc, 133(24): 9506-15. [Abstract] [Full-text]
80. Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder.
    Neuropsychopharmacology, 36(8): 1644-55. [Abstract] [Full-text]
81. The MATRICS consensus cognitive battery in patients with bipolar I disorder.
    Neuropsychopharmacology, 36(8): 1587-92. [Abstract] [Full-text]
82. Diagnostic Shifts During the Decade Following First Admission for Psychosis.
    Am J Psychiatry. [Abstract] [Full-text]
83. Impact of an educational program on the management of bipolar disorder in primary care.
    Bipolar Disord, 13(3): 318-22. [Abstract] [Full-text]
84. Menstrual effects on mood symptoms in treated women with bipolar disorder.
    Bipolar Disord, 13(3): 310-7. [Abstract] [Full-text]
85. Quality of life and impulsivity in bipolar disorder.
    Bipolar Disord, 13(3): 303-9. [Abstract] [Full-text]
86. Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report.
    Bipolar Disord, 13(3): 294-302. [Abstract] [Full-text]
87. Negative emotion impacts memory for verbal discourse in pediatric bipolar disorder.
    Bipolar Disord, 13(3): 287-93. [Abstract] [Full-text]
88. A functional MRI study of working memory in adolescents and young adults at genetic risk for bipolar disorder: preliminary findings.
    Bipolar Disord, 13(3): 272-86. [Abstract] [Full-text]
89. The genetic and environmental influences of event-related gamma oscillations on bipolar disorder.
    Bipolar Disord, 13(3): 260-71. [Abstract] [Full-text]
90. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males.
    Bipolar Disord, 13(3): 250-9. [Abstract] [Full-text]
91. The role of disturbed sleep in the early recognition of bipolar disorder: a systematic review.
    Bipolar Disord, 13(3): 227-37. [Abstract] [Full-text]
92. The lithiumeter: a measured approach.
    Bipolar Disord, 13(3): 219-26. [Abstract] [Full-text]
93. Pharmacogenomics of antidepressant induced mania: A review and meta-analysis of the serotonin transporter gene (5HTTLPR) association.
    J Affect Disord. [Abstract] [Full-text]
94. Mental health service use before and after diagnosis of early-onset bipolar disorder.
    J Behav Health Serv Res, 38(3): 398-413. [Abstract] [Full-text]
95. Olfactory identification and preference in bipolar disorder and schizophrenia.
    Eur Arch Psychiatry Clin Neurosci, 261(4): 251-9. [Abstract] [Full-text]
96. Functional remediation for bipolar disorder.
    Clin Pract Epidemiol Ment Health, 7: 112-6. [Abstract] [Full-text]
97. Gender differences in firesetting: Results from the national epidemiologic survey on alcohol and related conditions (NESARC).
    Psychiatry Res. [Abstract] [Full-text]
98. Modality-specific alterations in the perception of emotional stimuli in Bipolar Disorder compared to Healthy Controls and Major Depressive Disorder.
    Cortex. [Abstract] [Full-text]
99. Impulse control disorder comorbidity among patients with bipolar I disorder.
    Compr Psychiatry, 52(4): 378-85. [Abstract] [Full-text]
100. Distress due to lithium-induced polyuria: exploratory study.
     Psychiatry Clin Neurosci, 65(4): 386-8. [Abstract] [Full-text]
101. Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy.
     J Biomed Sci, 18: 29. [Abstract] [Full-text]
102. Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli.
     Physiol Behav, 104(2): 205-14. [Abstract] [Full-text]
103. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
     Int J Neuropsychopharmacol, 14(6): 721-34. [Abstract] [Full-text]
104. Antidepressants and psychostimulants in pediatric populations: is there an association with mania?
     Paediatr Drugs, 13(4): 225-43. [Abstract] [Full-text]
105. Outcome of patients with lithium poisoning at a far-east poison center.
     Hum Exp Toxicol, 30(7): 528-34. [Abstract] [Full-text]
106. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.
     Psychiatry Res. [Abstract] [Full-text]
107. The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.
     J Pharmacol Exp Ther, 338(1): 100-13. [Abstract] [Full-text]
108. Characterization and Factors Associated with Sleep Quality in Adolescents with Bipolar I Disorder.
     Child Psychiatry Hum Dev. [Abstract] [Full-text]
109. MRI exploration of pineal volume in bipolar disorder.
     J Affect Disord. [Abstract] [Full-text]
110. Childhood attention deficit hyperactivity disorder features in adult mood disorders.
     Compr Psychiatry. [Abstract] [Full-text]
111. No association of the YWHAE gene with schizophrenia, major depressive disorder or bipolar disorder in the Han Chinese population.
     Behav Genet, 41(4): 557-64. [Abstract] [Full-text]
112. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
     Schizophr Bull, 37(4): 727-36. [Abstract] [Full-text]
113. Is risk for mania associated with increased daydreaming as a form of mental imagery?
     J Affect Disord. [Abstract] [Full-text]
114. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
     Clin Ther, 33(6): 738-45. [Abstract] [Full-text]
115. D-serine: the right or wrong isoform?
     Brain Res, 1401: 104-17. [Abstract] [Full-text]
116. Olfactocentric paralimbic cortex morphology in adolescents with bipolar disorder.
     Brain, 134: 2005-12. [Abstract] [Full-text]
117. Patients' reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature.
     Int J Nurs Stud, 48(7): 894-903. [Abstract] [Full-text]
118. Social rhythms and vulnerability to bipolar disorder.
     J Affect Disord. [Abstract] [Full-text]
119. An examination of single nucleotide polymorphism selection prioritization strategies for tests of gene-gene interaction.
     Biol Psychiatry, 70(2): 198-203. [Abstract] [Full-text]
120. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder.
     Neuropsychology, 25(4): 499-510. [Abstract] [Full-text]
121. Genome-wide association study of personality traits in bipolar patients.
     Psychiatr Genet, 21(4): 190-4. [Abstract] [Full-text]
122. Strategies to identify genes for complex disorders: a focus on bipolar disorder and chromosome 16p.
     Psychiatr Genet, 21(4): 173-82. [Abstract] [Full-text]
123. Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.
     Med Res Rev, 31(4): 483-519. [Abstract] [Full-text]
124. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.
     J Psychiatry Neurosci, 36(4): 110011. [Abstract] [Full-text]
125. Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling.
     Cell Biosci, 1(1): 18. [Abstract] [Full-text]
126. Social cognition moderates the influence of child physical abuse on inpatient psychiatric rehabilitation.
     J Nerv Ment Dis, 199(7): 465-70. [Abstract] [Full-text]
127. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder.
     J Nerv Ment Dis, 199(7): 459-64. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.